Debt-to-equity of AGILE THERAPEUTICS INC from 30 Sep 2020 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
AGILE THERAPEUTICS INC quarterly Debt-to-equity in % history and change rate from 30 Sep 2020 to 30 Jun 2024.
  • AGILE THERAPEUTICS INC Debt-to-equity for the quarter ending 30 Jun 2024 was -180%, a 39% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

AGILE THERAPEUTICS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2024 -180% +116% +39% 30 Jun 2024
Q1 2024 -191% +416% +69% 31 Mar 2024
Q4 2023 -194% +726% +79% 31 Dec 2023
Q3 2023 -230% +5583% +96% 30 Sep 2023
Q2 2023 -296% -1386% -127% 30 Jun 2023
Q1 2023 -607% -972% -266% 31 Mar 2023
Q4 2022 -920% -1073% -702% 31 Dec 2022
Q3 2022 -5813% -5899% -6932% 30 Sep 2022
Q2 2022 1090% +1034% +1826% 30 Jun 2022
Q1 2022 366% +325% +803% 31 Mar 2022
Q4 2021 153% +122% +401% 31 Dec 2021
Q3 2021 85% +61% +256% 30 Sep 2021
Q2 2021 57% 30 Jun 2021
Q1 2021 41% 31 Mar 2021
Q4 2020 31% 31 Dec 2020
Q3 2020 24% 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.